NIPH
BIIB icon

NN Investment Partners Holdings’s Biogen BIIB Stock Holding History

NN Investment Partners Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13.2M Buy
62,633
+21,839
+54% +$4.75M 0.07% 227
2021
Q4 		$9.79M Buy
40,794
+2,316
+6% +$595K 0.05% 292
2021
Q3 		$10.9M Buy
38,478
+8,264
+27% +$2.71M 0.06% 262
2021
Q2 		$10.5M Buy
30,214
+1,391
+5% +$421K 0.06% 280
2021
Q1 		$8.06M Sell
28,823
-901
-3% -$243K 0.05% 307
2020
Q4 		$7.28M Sell
29,724
-16,318
-35% -$4.21M 0.04% 310
2020
Q3 		$13.1M Buy
46,042
+5,992
+15% +$1.67M 0.08% 195
2020
Q2 		$10.7M Buy
40,050
+2,274
+6% +$684K 0.07% 215
2020
Q1 		$11.9M Sell
37,776
-15,653
-29% -$4.75M 0.1% 183
2019
Q4 		$15.9M Sell
53,429
-23,008
-30% -$6.38M 0.11% 190
2019
Q3 		$17.8M Sell
76,437
-221,206
-74% -$51.5M 0.14% 157
2019
Q2 		$69.6M Buy
297,643
+379
+0.1% +$87.5K 0.55% 39
2019
Q1 		$70.3M Buy
297,264
+60,012
+25% +$18.9M 0.55% 40
2018
Q4 		$71.4M Buy
237,252
+106,011
+81% +$33.8M 0.6% 36
2018
Q3 		$46.4M Sell
131,241
-918
-0.7% -$316K 0.33% 69
2018
Q2 		$38.4M Sell
132,159
-53,472
-29% -$15M 0.28% 90
2018
Q1 		$50.8M Sell
185,631
-158,587
-46% -$49.2M 0.37% 75
2017
Q4 		$110M Buy
344,218
+165,910
+93% +$53.2M 0.77% 31
2017
Q3 		$55.8M Buy
178,308
+39,584
+29% +$11.7M 0.36% 80
2017
Q2 		$37.6M Sell
138,724
-10,701
-7% -$2.83M 0.35% 81
2017
Q1 		$40.9M Buy
149,425
+3,828
+3% +$1.08M 0.39% 71
2016
Q4 		$41.3M Buy
145,597
+11,276
+8% +$3.34M 0.39% 71
2016
Q3 		$42M Buy
134,321
+20,918
+18% +$6.2M 0.4% 76
2016
Q2 		$27.4M Sell
113,403
-76,398
-40% -$20.1M 0.26% 110
2016
Q1 		$49.4M Buy
+189,801
New +$50.1M 0.47% 73

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

NN Investment Partners Holdings's BIIB Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Biogen (BIIB) stake by 54% in Q1 2022, buying an estimated $4.75M and bringing the position to 62,633 shares worth $13.2M. The position accounts for 0.07% of the portfolio, ranked #227.

NN Investment Partners Holdings first reported a position in BIIB in Q1 2016 and has held it in 25 quarters since. The position peaked at $110M in Q4 2017. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • NN Investment Partners Holdings held 62,633 shares of Biogen worth $13.2M as of Q1 2022.
  • NN Investment Partners Holdings bought 21,839 Biogen shares in Q1 2022, an estimated $4.75M.
  • Biogen made up 0.07% of NN Investment Partners Holdings's portfolio in Q1 2022, its #227 holding.
  • NN Investment Partners Holdings first reported a position in Biogen in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Biogen position peaked at $110M in Q4 2017.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.